APC anti-mouse CD115 (CSF-1R) Antibody
- 产品名称：
- APC anti-mouse CD115 (CSF-1R) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 135509
- 产品应用：
- 135509
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: blocking of ligand binding1. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays.
It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation.?Pre-treatment with EDTA and low temperatures (2 to 8°C) helps in maintaining surface expression of CD1154.
- Application References
(PubMed link indicates BioLegend citation) -
- Sudo T, et al. 1995. Oncogene 11:2469.
- Murayama T, et al. 1999. Circulation 99:1740.
- Jaeger BN, et al. 2012. J. Exp. Med. 209:565. PubMed
- Breslin WL, et al. 2013. J Immunol Methods. 390(1-2):1 PubMed
- Dong L, et al. 2016. Nature. 539:304–308. PubMed
- Product Citations
-
- Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
- Andrés-Blasco I, et al. 2015. J Endocrinol. 227: 179 - 191. PubMed
- Hu S, et al. 2018. Front Immunol. 9:01. PubMed
- Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
- Accarias S, et al. 2020. J Cell Sci. 133:. PubMed
- Mason HD, et al. 2021. JCI Insight. 6:e149229. PubMed
- Fujii Y, et al. 2022. JBMR Plus. 6:e10562. PubMed
- Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
- Kobori T, et al. 2018. Front Immunol. 9:334. PubMed
- Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
- Hong H, et al. 2013. Biochem Biophys Res Commun. 440:545. PubMed
- Pedragosa J, et al. 2020. J Cereb Blood Flow Metab. 40:S98. PubMed
- Svahn S, et al. 2015. Infect Immun . 83:514. PubMed
- Izquierdo-Useros N, et al. 2014. J Immunol . 192:4852-4858. PubMed
- He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
- Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
- Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
- Saulnier N, et al. 2013. PLoS One. 7:30788. PubMed
- Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
- Herrero–Cervera A, et al. 2019. Diabetologia. 62:2143. PubMed
- Sauter K, et al. 2014. J Leukoc Biol. 96:265. PubMed
- Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
- Svahn S, et al. 2016. Infect Immun . 84: 1205-1213. PubMed
- Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
- Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
- Ledo JH, et al. 2020. PLoS One. e0237773:15. PubMed
- Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
- Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
- Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
- Baratin M, et al. 2017. Immunity. 47:349. PubMed
- T?htinen S, et al. 2022. Nat Immunol. 23:532. PubMed
- Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
- Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
- Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
- Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
- Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
- Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
- Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
- Park SM et al. 2018. Cell stem cell. 24(1):153-165 . PubMed
- O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
- Cleary MM, et al. 2021. Mol Cancer Ther. 20:906. PubMed
- Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
- Ledo JH, et al. 2020. Mol Psychiatry. . PubMed
- Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
- RRID
- AB_2085222 (BioLegend Cat. No. 135509) AB_2085221 (BioLegend Cat. No. 135510)
- Structure
- Ig superfamily, 145 kD
- Distribution
-
Monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, osteoclasts
- Function
- Growth factor receptor, tyrosine kinase
- Ligand/Receptor
- Macrophage colony stimulating factor (M-CSF), IL-34
- Cell Type
- Dendritic cells, Macrophages, Monocytes, Osteoclasts
- Biology Area
- Immunology
- Molecular Family
- CD Molecules, Cytokine/Chemokine Receptors
- Antigen References
-
- Sudo T, et al. 1995 Oncogene 11:2469.
- Murayama T, et al. 1999 Circulation 99:1740.
- Goswami S, et al. 2005 Cancer Res. 65:5278.
- Yu W, et al. 2008 J. Leuko. Biol. 84:852.
- Gene ID
- 12978 View all products for this Gene ID
- UniProt
- View information about CD115 on UniProt.org
